Cooley Closes 2nd Life Sciences Deal In 2 Days
Cooley LLP has closed its second sell-side pharmaceutical deal of the week, representing Presidio Pharmaceuticals Inc. in its $101 million acquisition by BioCryst Pharmaceutical Inc., announced Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article